KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Gross Margin (2016 - 2025)

Gilead Sciences' Gross Margin history spans 17 years, with the latest figure at 79.51% for Q4 2025.

  • For Q4 2025, Gross Margin rose 40.0% year-over-year to 79.51%; the TTM value through Dec 2025 reached 78.83%, up 57.0%, while the annual FY2025 figure was 78.83%, 57.0% up from the prior year.
  • Gross Margin reached 79.51% in Q4 2025 per GILD's latest filing, roughly flat from 79.8% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 83.52% in Q3 2021 to a low of 63.74% in Q4 2021.
  • Average Gross Margin over 5 years is 77.64%, with a median of 78.27% recorded in 2023.
  • Peak YoY movement for Gross Margin: tumbled -1743bps in 2021, then surged 1737bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 63.74% in 2021, then rose by 27bps to 81.11% in 2022, then fell by -13bps to 70.62% in 2023, then grew by 12bps to 79.11% in 2024, then rose by 1bps to 79.51% in 2025.
  • Per Business Quant, the three most recent readings for GILD's Gross Margin are 79.51% (Q4 2025), 79.8% (Q3 2025), and 78.81% (Q2 2025).